Search clinical trials for: Progressive Malignant Pleural Mesothelioma
Total 8479 results
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Metastatic Cancer | Malignant Mesothelioma | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Puerto Rico, Italy
-
Infinity Pharmaceuticals, Inc.Active, not recruitingAdvanced Solid Tumors (Part A/B/C/D) | Non-small Cell Lung Cancer (Part E) | Melanoma (Part E) | Squamous Cell Cancer of the Head and Neck (Part E) | Triple Negative Breast Cancer (Part F) | Adrenocortical Carcinoma (Part G) | Mesothelioma (Part G) | High-circulating Myeloid-derived Suppressor Cells...United States
-
Baylor College of MedicineTerminated
-
Mayo ClinicCSA Medical, Inc.Terminated
-
Centre Hospitalier Intercommunal CreteilCompleted
-
Massachusetts General HospitalActive, not recruitingNon Small Cell Lung Cancer | Mesothelioma | Small-cell Lung Cancer | Cognitive Behavioral TherapyUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Pleural Malignant Mesothelioma | Stage IV Pleural MesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedMesotheliomaUnited States
-
Trizell LtdUniversity of PennsylvaniaActive, not recruitingMalignant Pleural MesotheliomaFrance, United States, Australia, Germany, United Kingdom, Russian Federation, Canada, Italy, Poland
-
Mohamed Reda AshourActive, not recruitingHemothorax | Pleural Diseases | Pulmonary Atelectasis | Pleural Neoplasms | Pleural Effusion, Malignant | Mediastinal Lymphadenopathy | Pericardial Effusion | Pleural Empyema | Pleural Mesothelioma | Pneumothorax and Air Leak | Pulmonary Diseases or Conditions | PyopneumothoraxEgypt
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
University of ZurichSwiss National Science Foundation; Swiss Accident Insurance Fund SUVACompletedMalignant Pleural MesotheliomaSwitzerland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Recurrent Pleural Malignant Mesothelioma | Stage III Pleural Malignant Mesothelioma AJCC v7 | Stage IV Pleural Malignant Mesothelioma AJCC v7 | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | HLA-A*0201 Positive... and other conditionsUnited States
-
MaxCyte, Inc.CTI Clinical Trial and Consulting ServicesTerminatedFallopian Tube Adenocarcinoma | Peritoneal Mesothelioma | Primary Peritoneal Carcinoma | Adenocarcinoma of the OvaryUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedDepression | Small Cell Lung Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Malignant Mesothelioma | Non-small Cell Lung Cancer | Liver Cancer | Anxiety Disorder | Extrahepatic Bile Duct CancerUnited States
-
CanBas Co. Ltd.CompletedSolid Tumors | Malignant Pleural MesotheliomaUnited States
-
Jonsson Comprehensive Cancer CenterWithdrawnMesotheliomaUnited States
-
Health Pharma Professional ResearchWithdrawnMalignant Pleural Mesothelioma, Advanced | Malignant Pleural Mesothelioma, UnresectableMexico
-
Burzynski Research InstituteTerminatedMalignant MesotheliomaUnited States
-
NanoAlvandCompletedNon Small Cell Lung Cancer | Malignant Pleural Mesothelioma
-
National Cancer Institute (NCI)Completed
-
Epizyme, Inc.CompletedMesothelioma | BAP1 Loss of FunctionUnited States, United Kingdom, France
-
Intergroupe Francophone de Cancerologie ThoraciqueCompleted
-
Istituto Clinico HumanitasCompletedMesothelioma, MalignantItaly
-
Armando Santoro, MDCompletedNonsquamous Nonsmall Cell Neoplasm of Lung | Malignant Pleural MesotheliomaItaly
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Stage IA Malignant Mesothelioma | Stage IB Malignant Mesothelioma | Stage II Malignant Mesothelioma | Stage III Malignant Mesothelioma | Stage IV Malignant MesotheliomaUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | MesotheliomaUnited States, Canada
-
Raphael Bueno, MDMerck Sharp & Dohme LLCWithdrawn
-
BayerImmunoGen and MorphoSysCompletedMesotheliomaBelgium, France, United States, Canada, Spain, Turkey, United Kingdom, Australia, Finland, Italy, Poland, Korea, Republic of, Netherlands, Russian Federation
-
Merck Sharp & Dohme LLCCompleted
-
University of Texas Southwestern Medical CenterUniversity of Chicago; Columbia University; Duke UniversityCompletedMesotheliomaUnited States
-
Targovax OyTheradexUnknownTo Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With ChemotherapySpain, France
-
Istituto Clinico HumanitasCompletedMesothelioma, MalignantItaly
-
Aduro Biotech, Inc.CompletedMalignant Pleural MesotheliomaUnited States
-
Polaris GroupTerminatedGlioma | Hepatocellular Carcinoma | Uveal Melanoma | Sarcomatoid Carcinoma | Pleural Mesothelioma Malignant Advanced | Peritoneal Mesothelioma Malignant Advanced | Non-squamous Non-small Cell Lung CarcinomaUnited States, United Kingdom
-
Kissei Pharmaceutical Co., Ltd.CompletedMalignant Pleural MesotheliomaJapan
-
Papworth Hospital NHS Foundation TrustLondon School of Hygiene and Tropical Medicine; King's College London; University... and other collaboratorsCompletedMalignant Pleural Mesothelioma | Trapped LungUnited Kingdom
-
Columbia UniversityTerminated
-
Jonsson Comprehensive Cancer CenterCompletedLung Cancer | Metastatic Cancer | Malignant Mesothelioma | Thymoma and Thymic CarcinomaUnited States
-
Gruppo Oncologico Italiano di Ricerca ClinicaUnknown
-
Jonsson Comprehensive Cancer CenterTerminatedPleural Epithelioid Mesothelioma | Pleural Malignant MesotheliomaUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseCompletedRenal Cell Carcinoma | Cholangiocarcinoma | Malignant Pleural Mesothelioma (MPM) | Choroidal Nevus | Primary Uveal Melanoma (UM) | Metastatic Uveal Melanoma (UM)United States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)Completed
-
Incyte CorporationWithdrawnAdvanced and/or Metastatic Solid Tumors | Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer | Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPleural Malignant MesotheliomaUnited States
-
MorphotekTerminatedMesothelioma, MalignantFrance, United Kingdom, United States, Germany, Australia, Italy
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMalignant MesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedSarcoma | Esophageal Cancer | Thymic Carcinoma | Lung Cancer | Malignant Pleural MesotheliomaUnited States